Feb 11 (Reuters) - Swiss pharmaceutical giant Novartis (NOVN.S), opens new tab has agreed to acquire Anthos Therapeutics, a biopharma firm majority-owned by Blackstone's (BX.N), opens new tab drug ...

Anthos on Microsoft Azure is being tested with customers. Google Cloud, which continues to boost the capabilities of its hybrid and multi-cloud Anthos platform, today announced the general ...

Google Cloud also will disclose that Anthos on Microsoft Azure is being tested with customers and Anthos support for virtual machines is in early preview with customers. Google Cloud, which ...

Blackstone Life Sciences has sold Anthos Therapeutics to Novartis for up to $3.1 billion. Anthos is a transformative, clinical-stage biopharmaceutical company developing innovative therapies for ...